A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS

Clinical trial NCT05788679 · RECRUITING

Trial details

NCT number: NCT05788679
Sponsor: Karolinska University Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts Mixed Myelodysplastic/Myeloproliferative Disease

Start date: 2022-11-22
Primary completion: 2026-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.